Iridian Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $754K | Sell |
2,827
-817
| -22% | -$221K | 0.31% | 36 |
|
|
2025
Q4 | $914K | Sell |
3,644
-349
| -9% | -$92.7K | 0.34% | 36 |
|
|
2025
Q3 | $1.15M | Buy |
3,993
+86
| +2% | +$23K | 0.45% | 38 |
|
|
2025
Q2 | $1.03M | Sell |
3,907
-316
| -7% | -$76.9K | 0.36% | 37 |
|
|
2025
Q1 | $983K | Sell |
4,223
-16,272
| -79% | -$3.95M | 0.31% | 37 |
|
|
2024
Q4 | $4.7M | Sell |
20,495
-1,721
| -8% | -$395K | 1.25% | 28 |
|
|
2024
Q3 | $4.96M | Sell |
22,216
-9,393
| -30% | -$2.06M | 1.06% | 27 |
|
|
2024
Q2 | $6.43M | Buy |
31,609
+8,487
| +37% | +$1.73M | 1.45% | 19 |
|
|
2024
Q1 | $5.05M | Sell |
23,122
-1,726
| -7% | -$380K | 0.99% | 29 |
|
|
2023
Q4 | $5.65M | Sell |
24,848
-75,668
| -75% | -$15.9M | 1.02% | 25 |
|
|
2023
Q3 | $20.2M | Sell |
100,516
-117,388
| -54% | -$24.8M | 4.09% | 10 |
|
|
2023
Q2 | $45.2M | Sell |
217,904
-4,361
| -2% | -$846K | 4.21% | 4 |
|
|
2023
Q1 | $43.8M | Sell |
222,265
-14,295
| -6% | -$2.94M | 3.59% | 8 |
|
|
2022
Q4 | $47.9M | Buy |
236,560
+66,518
| +39% | +$13M | 4.61% | 6 |
|
|
2022
Q3 | $29.9M | Sell |
170,042
-84,172
| -33% | -$17.2M | 2.97% | 14 |
|
|
2022
Q2 | $51.2M | Buy |
254,214
+23,424
| +10% | +$4.99M | 4.19% | 5 |
|
|
2022
Q1 | $52.3M | Buy |
230,790
+21,993
| +11% | +$5.17M | 3.64% | 7 |
|
|
2021
Q4 | $56.4M | Sell |
208,797
-312,206
| -60% | -$77.3M | 3.45% | 6 |
|
|
2021
Q3 | $126M | Sell |
521,003
-500,171
| -49% | -$126M | 3.85% | 3 |
|
|
2021
Q2 | $242M | Sell |
1,021,174
-141,244
| -12% | -$32.2M | 4.23% | 1 |
|
|
2021
Q1 | $255M | Sell |
1,162,418
-72,601
| -6% | -$14.6M | 4.35% | 1 |
|
|
2020
Q4 | $216M | Sell |
1,235,019
-90,103
| -7% | -$15.6M | 3.93% | 3 |
|
|
2020
Q3 | $214M | Sell |
1,325,122
-81,761
| -6% | -$13M | 4.69% | 2 |
|
|
2020
Q2 | $201M | Sell |
1,406,883
-231,890
| -14% | -$32.1M | 4.43% | 2 |
|
|
2020
Q1 | $178M | Buy |
1,638,773
+94,465
| +6% | +$13.6M | 4.3% | 2 |
|
|
2019
Q4 | $224M | Buy |
1,544,308
+31,014
| +2% | +$4.48M | 3.68% | 4 |
|
|
2019
Q3 | $218M | Buy |
1,513,294
+314,270
| +26% | +$45.9M | 3.42% | 5 |
|
|
2019
Q2 | $178M | Buy |
1,199,024
+108,249
| +10% | +$15.1M | 2.57% | 12 |
|
|
2019
Q1 | $143M | Buy |
1,090,775
+251,947
| +30% | +$31M | 1.83% | 28 |
|
|
2018
Q4 | $91.1M | Sell |
838,828
-682,912
| -45% | -$91.5M | 1.22% | 39 |
|
|
2018
Q3 | $227M | Sell |
1,521,740
-525,629
| -26% | -$80M | 2.27% | 18 |
|
|
2018
Q2 | $316M | Buy |
2,047,369
+79,137
| +4% | +$11.9M | 2.92% | 5 |
|
|
2018
Q1 | $274M | Buy |
1,968,232
+84,617
| +4% | +$12.4M | 2.45% | 12 |
|
|
2017
Q4 | $258M | Buy |
1,883,615
+42,207
| +2% | +$5.58M | 2.17% | 17 |
|
|
2017
Q3 | $239M | Sell |
1,841,408
-21,316
| -1% | -$2.84M | 2.04% | 18 |
|
|
2017
Q2 | $247M | Sell |
1,862,724
-9,224
| -0.5% | -$1.13M | 2.18% | 16 |
|
|
2017
Q1 | $231M | Sell |
1,871,948
-76,541
| -4% | -$9.06M | 2.08% | 17 |
|
|
2016
Q4 | $215M | Buy |
1,948,489
+359,064
| +23% | +$39.9M | 1.98% | 23 |
|
|
2016
Q3 | $188M | Buy |
+1,589,425
| New | +$187M | 1.64% | 26 |
|
Other funds holding LH
VCM
VPM
Iridian Asset Management's LH Position: Q1 2026 in Review
Iridian Asset Management reduced its Labcorp (LH) stake by 22% in Q1 2026, selling an estimated $221K and leaving 2,827 shares worth $754K. The position accounts for 0.31% of the portfolio, ranked #36.
Iridian Asset Management first reported a position in LH in Q3 2016 and has held it in 39 quarters since. The position peaked at $316M in Q2 2018. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Iridian Asset Management held 2,827 shares of Labcorp worth $754K as of Q1 2026.
- Iridian Asset Management sold 817 Labcorp shares in Q1 2026, an estimated $221K.
- Labcorp made up 0.31% of Iridian Asset Management's portfolio in Q1 2026, its #36 holding.
- Iridian Asset Management first reported a position in Labcorp in Q3 2016 and has held it in 39 quarters since.
- Iridian Asset Management's Labcorp position peaked at $316M in Q2 2018.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Iridian Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.